TRCT
HCM icon

Tower Research Capital (TRC)’s HUTCHMED HCM Stock Holding History

Tower Research Capital (TRC)’s Portfolio HCM Stock Details HCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.6K Buy
642
+482
+301% +$7.05K ﹤0.01% 3921
2025
Q4 		$2.13K Sell
160
-1,902
-92% -$27.8K ﹤0.01% 4580
2025
Q3 		$32.5K Buy
2,062
+1,020
+98% +$16.8K ﹤0.01% 2874
2025
Q2 		$15.7K Buy
1,042
+12
+1% +$175 ﹤0.01% 3802
2025
Q1 		$15.5K Sell
1,030
-231
-18% -$3.42K ﹤0.01% 3218
2024
Q4 		$18.2K Sell
1,261
-2,234
-64% -$39.9K ﹤0.01% 3268
2024
Q3 		$68.3K Buy
3,495
+1,801
+106% +$32.6K ﹤0.01% 2536
2024
Q2 		$29K Sell
1,694
-2,964
-64% -$54.7K ﹤0.01% 3510
2024
Q1 		$78.3K Buy
4,658
+2,410
+107% +$36.6K ﹤0.01% 1973
2023
Q4 		$40.7K Sell
2,248
-3,475
-61% -$63.2K ﹤0.01% 3265
2023
Q3 		$96.9K Buy
5,723
+1,279
+29% +$18.3K ﹤0.01% 2004
2023
Q2 		$53.3K Sell
4,444
-4,487
-50% -$61.2K ﹤0.01% 2530
2023
Q1 		$116K Buy
8,931
+1,855
+26% +$30.4K ﹤0.01% 1730
2022
Q4 		$104K Sell
7,076
-22,641
-76% -$248K ﹤0.01% 1806
2022
Q3 		$263K Buy
29,717
+25,170
+554% +$317K ﹤0.01% 1660
2022
Q2 		$58K Buy
4,547
+1,601
+54% +$20.4K ﹤0.01% 2741
2022
Q1 		$55K Buy
2,946
+2,358
+401% +$60K ﹤0.01% 2654
2021
Q4 		$21K Sell
588
-10
-2% -$325 ﹤0.01% 3601
2021
Q3 		$22K Sell
598
-24,530
-98% -$965K ﹤0.01% 3631
2021
Q2 		$987K Buy
25,128
+23,550
+1,492% +$680K 0.03% 667
2021
Q1 		$45K Sell
1,578
-1,195
-43% -$38.1K ﹤0.01% 3216
2020
Q4 		$89K Sell
2,773
-1,932
-41% -$59.4K ﹤0.01% 2460
2020
Q3 		$152K Buy
4,705
+4,003
+570% +$125K ﹤0.01% 2812
2020
Q2 		$19K Sell
702
-395
-36% -$8.57K ﹤0.01% 3708
2020
Q1 		$20K Sell
1,097
-2,686
-71% -$64.8K ﹤0.01% 1710
2019
Q4 		$95K Buy
3,783
+617
+19% +$13.5K 0.01% 969
2019
Q3 		$56K Sell
3,166
-1,621
-34% -$33.8K ﹤0.01% 1710
2019
Q2 		$106K Buy
4,787
+4,479
+1,454% +$128K 0.01% 1142
2019
Q1 		$9K Buy
+308
New +$7.68K ﹤0.01% 2731
2018
Q4 		– Sell
-708
Closed -$23K – 4028
2018
Q3 		$23K Buy
+708
New +$21.6K ﹤0.01% 2248
2018
Q2 		– Sell
-200
Closed -$6K – 3824
2018
Q1 		$6K Buy
+200
New +$7.11K ﹤0.01% 2655
2017
Q4 		– Sell
-200
Closed -$5K – 3712
2017
Q3 		$5K Buy
200
+100
+100% +$2.46K ﹤0.01% 3304
2017
Q2 		$2K Sell
100
-100
-50% -$2.05K ﹤0.01% 2338
2017
Q1 		$4K Buy
+200
New +$3K ﹤0.01% 2318
2016
Q4 		– Sell
-304
Closed -$4K – 4048
2016
Q3 		$4K Sell
304
-307
-50% -$3.92K ﹤0.01% 2675
2016
Q2 		$8K Sell
611
-650
-52% -$8.61K ﹤0.01% 3023
2016
Q1 		$17K Buy
+1,261
New +$16.9K ﹤0.01% 1473

Other funds holding HCM

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AG
AIA Group Hong Kong $6.88B AUM 20.97% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Tower Research Capital (TRC)'s HCM Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its HUTCHMED (HCM) stake by 301% in Q1 2026, buying an estimated $7.05K and bringing the position to 642 shares worth $9.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3921.

Tower Research Capital (TRC) first reported a position in HCM in Q1 2016 and has held it in 37 quarters since. The position peaked at $987K in Q2 2021. 54 funds tracked by Wall St. Rank hold HCM as of Q1 2026.

  • Tower Research Capital (TRC) held 642 shares of HUTCHMED worth $9.6K as of Q1 2026.
  • Tower Research Capital (TRC) bought 482 HUTCHMED shares in Q1 2026, an estimated $7.05K.
  • HUTCHMED made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #3921 holding.
  • Tower Research Capital (TRC) first reported a position in HUTCHMED in Q1 2016 and has held it in 37 quarters since.
  • Tower Research Capital (TRC)'s HUTCHMED position peaked at $987K in Q2 2021.
  • 54 funds tracked by Wall St. Rank held HUTCHMED as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.